Parenteral Drugs (India) Ltd.

    Parenteral Drugs (India) Ltd.

    NNSE:PDPL
    - -
    INR
    - -
    - -
    Parenteral Drugs (India) Ltd.
    NSE:PDPL
    (National Stock Exchange of India)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2007
    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    TTM
    INR
    116.16
    139.87
    128.85
    219.29
    186.54
    124.34
    119.6
    86.46
    84.23
    82.94
    80.1
    75.77
    10.73
    8.06
    4.08
    2.85
    2.85
    Revenue per Share
    3.19
    12.57
    5.59
    16.11
    1.71
    -20.64
    -41.69
    -15.15
    -22.69
    -39.09
    -39.52
    -37.5
    -49.61
    -38.26
    -40.82
    -25.61
    -25.61
    Basic EPS, GAAP
    -9.54
    -43.51
    -26.67
    -27.57
    -12.16
    -49.67
    -72.94
    -58.36
    -2.44
    -17.45
    44.93
    55.53
    159.99
    37.69
    -0.04
    -0.16
    - -
    Free Cash Flow per Basic Share
    0.56
    1.13
    1.2
    2
    0.89
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    32.94
    70.86
    115.65
    127.29
    135.46
    130.32
    88.47
    62.7
    37.47
    33.74
    -11.85
    -45.76
    -149.89
    -188.25
    -229.03
    -276.37
    -276.37
    Book Value per Share
    32.94
    70.86
    61.18
    76.19
    84.36
    79.22
    37.37
    18.37
    -5.7
    33.74
    -11.85
    -45.76
    -149.89
    -188.25
    -229.03
    -276.37
    -276.37
    Tangible Book Value per Share
    15
    15
    21
    19
    26
    26
    26
    30
    30
    30
    30
    30
    30
    30
    30
    30
    30
    Basic Weighted Avg Shares
    1,735
    2,130
    2,694
    4,145
    4,822
    3,216
    3,094
    2,578
    2,511
    2,473
    2,388
    2,259
    320
    240
    122
    85
    85
    Sales/Revenue/Turnover
    8.13
    16.09
    12.72
    13.8
    7.84
    -0.01
    -11.9
    -18.65
    -6.77
    -22.85
    -9.82
    -10.02
    -271.2
    -131.48
    -239.15
    -649.25
    -649.25
    Operating Margin (%)
    28
    45
    70
    90
    126
    145
    230
    186
    310
    228
    249
    242
    691
    173
    173
    401
    401
    Depreciation Expense
    48
    191
    117
    304
    44
    -534
    -1,078
    -452
    -677
    -1,165
    -1,178
    -1,118
    -1,479
    -1,141
    -1,217
    -764
    -764
    Net Income, GAAP
    36.52
    18.5
    37.97
    23.37
    45.87
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    2.75
    8.99
    4.34
    7.35
    0.92
    -16.6
    -34.86
    -17.52
    -26.94
    -47.13
    -49.34
    -49.49
    -462.23
    -474.81
    -1,000.31
    -898.77
    -898.77
    Profit Margin (%)
    698
    1,306
    1,698
    1,939
    1,852
    -528
    304
    340
    51
    -1,541
    -3,058
    -4,935
    -8,102
    -9,382
    -10,756
    -11,337
    -11,337
    Working Capital
    991
    1,043
    1,881
    2,558
    3,258
    2,096
    3,663
    4,000
    4,123
    4,358
    3,807
    3,086
    330
    305
    305
    1,072
    1,072
    LT Debt
    492
    1,312
    2,808
    3,298
    3,510
    3,497
    2,469
    2,030
    1,278
    1,009
    -172
    -1,362
    -4,468
    -5,612
    -6,828
    -8,239
    -8,239
    Total Equity
    6.87
    14.16
    5.9
    8.12
    3.19
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    3.75
    9.98
    3.32
    5.77
    0.61
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    10.6
    21.24
    5.67
    9.98
    1.3
    -15.53
    -38.11
    -21.73
    -45.31
    -109.79
    - -
    - -
    - -
    - -
    - -
    - -
    -407.39
    Return on Common Equity (%)

    Capital Structure

    INR

    •

    in mil. unless spec.
    Sep'22
    Dec'22
    Mar'22
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    1,073
    - -
    1,072
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    30
    30
    30
    Market Capitalization
    85
    113
    107

    Working Capital

    INR

    •

    in mil. unless spec.
    Sep'22
    Dec'22
    Mar'22
    Total Current Assets
    673
    - -
    671
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    6
    - -
    10
    Total Current Liabilities
    12,183
    - -
    12,008
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    INR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    76.72%
    197.9%
    20.67%
    Free Cash Flow
    57.15%
    74.16%
    335.65%
    Net Income, GAAP
    14.08%
    -5.25%
    -37.26%
    Sales/Revenue/Turnover
    -22.37%
    -39.14%
    -30.17%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    87
    73
    72
    7
    240
    2021
    29
    46
    20
    26
    122
    2022
    29
    24
    14
    18
    85

    Quarterly Earnings Per Share

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    -9.29
    -9.5
    -8.77
    - -
    -38.26
    2021
    -10.81
    -11.29
    -10.39
    - -
    -40.82
    2022
    -10.74
    -11.27
    -11.58
    - -
    -25.61

    Quarterly Dividends Per Share

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    - -
    - -
    - -
    - -
    - -
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business